D-0825-2018 Class II Terminated

Recalled by Mylan Pharmaceuticals Inc. — Morgantown, WV

Recall Details

Product Type
Drugs
Report Date
May 30, 2018
Initiation Date
April 24, 2018
Termination Date
August 14, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
11,650 bottles

Product Description

Loxapine Capsules, USP 50 mg, Rx Only, 100-count bottles, NDC 0378-7050-01

Reason for Recall

CGMP Deviations

Distribution Pattern

Product was distributed throughout the United States, including Puerto Rico.

Code Information

NDC 0378-7050-01 Lot Numbers: 3079386, Exp. 10/31/18 3079387, Exp. 10/31/18 3079388, Exp. 10/31/18 3083762, Exp. 3/31/19 3083763, Exp. 3/31/19 3083764, Exp. 3/31/19 3083765, Exp. 3/31/19 3083766, Exp. 3/31/19 3083767, Exp. 3/31/19